Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

CAR-T Meeting 2020 | Sleeping beauty awakens: a novel approach to engineering CIK CAR cells

Sarah Tettamanti • 31 Jan 2020
CAR-T Meeting 2020
General CAR-T

Sarah Tettamanti, PhD, Matilde Tettamanti Research Center, MBBM Foundation, San Gerardo Hospital, Monza, Italy, gives an overview of her flash talk on engineering cytokine-induced killer cells (CIK) in order to express CD33.CAR via a novel sleeping beauty transposon system. This interview took place at the 2nd European CAR T-Cell Meeting in Sitges, Spain.

Related Videos

From immunosuppression to targeted immunomodulation: emerging treatment strategies in GvHD
2:58
From immunosuppression to targeted immunomodulation: emerging treatment strategies in GvHD
Iskra Pusic • 11 Sep 2026
Three-year survival update of pre-induction azacitidine and venetoclax in newly diagnosed AML
3:46
Three-year survival update of pre-induction azacitidine and venetoclax in newly diagnosed AML
Maher Salamoon • 8 Sep 2026
Understanding the risks of lymphoproliferative disorders following CAR T-cell therapy
2:01
Understanding the risks of lymphoproliferative disorders following CAR T-cell therapy
Michael Jain • 11 Sep 2026
Long-term survivorship after CAR T-cell therapy: addressing non-relapse mortality
1:46
Long-term survivorship after CAR T-cell therapy: addressing non-relapse mortality
Michael Jain • 11 Sep 2026
The content of VJHemOnc is intended for healthcare professionals